These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 399593)

  • 21. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
    Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA; Bridgman KM; Ebbutt AF
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract]   [Full Text] [Related]  

  • 23. Slow release oxprenolol in angina pectoris [proceedings].
    Goldstraw PW; Taylor SH; Thadani U; Watt SJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):387P. PubMed ID: 332219
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypotensive effect of oxprenolol in mild hypertension: a co-operative controlled study.
    Muiesan G; Motolese M; Colombi A
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():163s-6. PubMed ID: 4593563
    [No Abstract]   [Full Text] [Related]  

  • 25. European infarction study (EIS). A secondary prevention study with slow release oxprenolol after myocardial infarction.
    Eur Heart J; 1982 Dec; 3(6):583-6. PubMed ID: 6761123
    [No Abstract]   [Full Text] [Related]  

  • 26. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
    Albanesi Filho FM; Benchimol AB
    Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical responses to oxprenolol in the elderly.
    Ellis RA
    Am J Cardiol; 1983 Nov; 52(9):62D-65D. PubMed ID: 6356866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the effects of oxprenolol and nifedipine on blood pressure at rest and during physical exercise in essential hypertension].
    Gambini G; Pizzuti C; Valori C
    Clin Ter; 1988 Feb; 124(3):203-10. PubMed ID: 2974332
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of hypertension with a new combination of beta blocking agents and saluretics].
    Deibert K
    Med Welt; 1980 Sep; 31(36):1288-90. PubMed ID: 7442528
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice study.
    Forrest WA
    Br J Clin Pract; 1973 Sep; 27(9):331-5. PubMed ID: 4595072
    [No Abstract]   [Full Text] [Related]  

  • 31. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 33. One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.
    Masoni A; Tomasi AM; Pirani R; Lazzaretto R; Ambroso G
    G Ital Cardiol; 1981; 11(12):2105-9. PubMed ID: 7346306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
    Wilcox RG; Hampton JR
    Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effect of oxprenolol and chlorthalidone in fixed combination, given once daily.
    Buoninconti R; Motolese M; Rubegni M
    J Int Med Res; 1979; 7(6):519-23. PubMed ID: 391625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 37. Antihypertensive effectiveness of oxprenolol administered twice daily.
    Materson BJ; Oster JR; Michael UF; Perez-Stable EC
    Clin Pharmacol Ther; 1976 Mar; 19(3):325-32. PubMed ID: 770050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An example of an acceptable combination in the treatment of arterial hypertension].
    Menard J; Plouin PF; Gouin F; Corvol P; Milliez P
    Sem Hop; 1978 Feb; 54(4):201-6. PubMed ID: 208167
    [No Abstract]   [Full Text] [Related]  

  • 39. [Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day].
    Fariello R; Alicandri C; Boni E; Montini E; Zaninelli A; Agabiti-Rosei E; Motolese M; Muiesan G
    G Ital Cardiol; 1984 Feb; 14(2):121-6. PubMed ID: 6714549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings: A trial of the combination of guanethidine and oxprenolol in hypertension.
    Pearson RM; Bulpitt C; George CF; Hole D; Breckenridge A
    Scott Med J; 1974 Jan; 19(1):45-6. PubMed ID: 4594824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.